List of Excipients in API hydroxychloroquine sulfate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydroxychloroquine sulfate
Excipients in ANDA-approved (generic) drugs containing hydroxychloroquine sulfate
Detailed excipient profiles for hydroxychloroquine sulfate
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
hydroxychloroquine sulfate drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
hydroxychloroquine sulfate drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
hydroxychloroquine sulfate drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Mylan Institutional Inc | hydroxychloroquine sulfate | 42292-011 |
| Aphena Pharma Solutions - Tennessee LLC | hydroxychloroquine sulfate | 71610-507 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
hydroxychloroquine sulfate drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
hydroxychloroquine sulfate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
hydroxychloroquine sulfate drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
hydroxychloroquine sulfate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
Excipient focus: CARNAUBA WAX
hydroxychloroquine sulfate drug variants containing CARNAUBA WAX
hydroxychloroquine sulfate drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
hydroxychloroquine sulfate drug variants containing CELLULOSE, MICROCRYSTALLINE
hydroxychloroquine sulfate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
hydroxychloroquine sulfate drug variants containing CROSCARMELLOSE SODIUM
hydroxychloroquine sulfate drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
hydroxychloroquine sulfate drug variants containing CROSPOVIDONE
hydroxychloroquine sulfate drug variants not containing CROSPOVIDONE
Excipient focus: DEXTRATES
hydroxychloroquine sulfate drug variants containing DEXTRATES
hydroxychloroquine sulfate drug variants not containing DEXTRATES
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
hydroxychloroquine sulfate drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
hydroxychloroquine sulfate drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FERROSOFERRIC OXIDE
hydroxychloroquine sulfate drug variants containing FERROSOFERRIC OXIDE
hydroxychloroquine sulfate drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
hydroxychloroquine sulfate drug variants containing HYDROXYPROPYL CELLULOSE
hydroxychloroquine sulfate drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
hydroxychloroquine sulfate drug variants containing HYPROMELLOSE
hydroxychloroquine sulfate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
hydroxychloroquine sulfate drug variants containing HYPROMELLOSE 2910
hydroxychloroquine sulfate drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTOSE MONOHYDRATE
hydroxychloroquine sulfate drug variants containing LACTOSE MONOHYDRATE
hydroxychloroquine sulfate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
hydroxychloroquine sulfate drug variants containing MAGNESIUM STEARATE
hydroxychloroquine sulfate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
hydroxychloroquine sulfate drug variants containing MALTODEXTRIN
hydroxychloroquine sulfate drug variants not containing MALTODEXTRIN
Excipient focus: POLYDEXTROSE
hydroxychloroquine sulfate drug variants containing POLYDEXTROSE
hydroxychloroquine sulfate drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL 3350
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL 400
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL 4000
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
hydroxychloroquine sulfate drug variants containing POLYETHYLENE GLYCOL 8000
hydroxychloroquine sulfate drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
hydroxychloroquine sulfate drug variants containing POLYSORBATE 80
hydroxychloroquine sulfate drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
hydroxychloroquine sulfate drug variants containing POLYVINYL ALCOHOL
hydroxychloroquine sulfate drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
hydroxychloroquine sulfate drug variants containing POVIDONE
hydroxychloroquine sulfate drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
hydroxychloroquine sulfate drug variants containing POVIDONE K30
hydroxychloroquine sulfate drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
hydroxychloroquine sulfate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | hydroxychloroquine sulfate | 59746-780 |
| Havix Group Inc d-b-a Aavis Pharmaceuticals | hydroxychloroquine sulfate | 71337-019 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
hydroxychloroquine sulfate drug variants containing SHELLAC
hydroxychloroquine sulfate drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
hydroxychloroquine sulfate drug variants containing SILICON DIOXIDE
hydroxychloroquine sulfate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BICARBONATE
hydroxychloroquine sulfate drug variants containing SODIUM BICARBONATE
hydroxychloroquine sulfate drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM LAURYL SULFATE
hydroxychloroquine sulfate drug variants containing SODIUM LAURYL SULFATE
hydroxychloroquine sulfate drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
hydroxychloroquine sulfate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
hydroxychloroquine sulfate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
hydroxychloroquine sulfate drug variants containing STARCH, CORN
hydroxychloroquine sulfate drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
hydroxychloroquine sulfate drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | hydroxychloroquine sulfate | 68071-4648 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: SUCRALOSE
hydroxychloroquine sulfate drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novitium Pharma LLC | hydroxychloroquine sulfate | 70954-172 |
| ANI Pharmaceuticals Inc | hydroxychloroquine sulfate | 70954-804 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing SUCRALOSE
Excipient focus: TALC
hydroxychloroquine sulfate drug variants containing TALC
hydroxychloroquine sulfate drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
hydroxychloroquine sulfate drug variants containing TITANIUM DIOXIDE
hydroxychloroquine sulfate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | hydroxychloroquine sulfate | 16571-112 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
hydroxychloroquine sulfate drug variants containing TRIACETIN
hydroxychloroquine sulfate drug variants not containing TRIACETIN
Excipient focus: WATER
hydroxychloroquine sulfate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novitium Pharma LLC | hydroxychloroquine sulfate | 70954-172 |
| ANI Pharmaceuticals Inc | hydroxychloroquine sulfate | 70954-804 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine sulfate drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
